Inicio › Enfermedad de Parkinson › Florida
Ensayos clínicos de Enfermedad de Parkinson en Florida
34 estudios sobre Enfermedad de Parkinson buscan participantes en Florida.
Ciudades en Florida
- Miami13 estudios
- Tampa12 estudios
- Gainesville12 estudios
- Orlando10 estudios
- Boca Raton8 estudios
- Hollywood5 estudios
- Jacksonville3 estudios
- Naples3 estudios
- West Palm Beach3 estudios
- The Villages3 estudios
Texto oficial del estudio (inglés)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
- University of Florida, Gainesville
- Neurology One, Orlando
- y 1 más
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06680830A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Aqualane Clinical Research, Naples
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 30 a 80 · Todos los sexos · Actualizado el 1 oct 2026 · NCT06565195A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-038, Atlantis
- Site-017, Boca Raton
- Site-051, Maitland
ReclutandoFase 2/3
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- First Choice Neurology - Aventura Neurologic Associates, Aventura
- Arrow Clinical Trials, Daytona Beach
- Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU, DeLand
- y 3 más
ReclutandoFase 2/3
Edades de 40 a 85 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- University of Florida, Gainesville
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07005180Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- University of Florida Shands Hospital, Gainesville
- University of Miami Hospital, Miami
- University of South Florida, Tampa
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #065, Altamonte Springs
- Vima Site #054, Aventura
- Vima Site #008, Miami
- y 3 más
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Parkinson's Disease & Movement Disorders Center of Boca Raton (Site #227), Boca Raton
- UM-UHealth at Boca Raton (Site #226), Boca Raton
- Velocity Clinical Research - Hallandale Beach (Site #228), Hallandale
- y 3 más
ReclutandoFase 2
Edades de 30 a 80 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Parkinson's Disease & Movement Disorder Center of Boca Raton, Boca Raton
- University of Florida, Gainesville
- University of Miami, Miami
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Baptist Health Miami Neuroscience Institute, Miami
- AdventHealth Neuroscience Institute, Orlando
- University of South Florida, Tampa
ReclutandoEstudio observacional
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07330258Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- University of Miami Hospital, Miami
- University of South Florida, Tampa
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 3 sept 2026 · NCT03664609A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- JEM Research LLC, Atlantis
- Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
- K2 - Villages, Lady Lake
- y 5 más
ReclutandoFase 3
Edades de 50 a 85 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07174310Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD
- University of Florida, Gainesville
- Norman Fixel Institute for Neurological Diseases, Gainesville
Reclutando
Edades de 40 a 75 · Todos los sexos · Actualizado el 21 ago 2026 · NCT07674264A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Mayo Clinic Jacksonville - Neurology, Jacksonville
- University of Miami Health System - Neurology, Miami
- USF Parkinson's Disease and Movement Disorders Center, Tampa
ReclutandoFase 3
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06944522Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- UF - McKnight Brain Institute, Gainesville
Reclutando
Edades de 22 a 80 · Todos los sexos · Actualizado el 31 jul 2026 · NCT07207122PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Parkinson's Disease& Movement Disorder Center of Boca Raton, Boca Raton
- University of Florida, Gainesville
- University of South Florida, Tampa
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT04477785Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
- Institute for Neuroimmune Medicine, Davie
- Las Mercedes Medical Research, Hialeah
- NextGen Research Group, Miami
- y 1 más
ReclutandoFase 2
Edades de 30 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT05266417The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease
- University of Florida, Norman Fixel Institute for Neurological Diseases, Gainesville
Reclutando
Edades de 45 a 85 · Todos los sexos · Actualizado el 21 jul 2026 · NCT07026734Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease
- University of Florida, Gainesville
Reclutando
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 jul 2026 · NCT06911229Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
- University of Florida, Gainesville
Reclutando
Edades de 18 a 80 · Todos los sexos · Actualizado el 6 jul 2026 · NCT07410598Neurologic Stem Cell Treatment Study
- MD Stem Cells, Coral Springs
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 jun 2026 · NCT02795052SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Velocity Clinical Research, Hallandale
- K2 Medical Research LLC, Maitland
ReclutandoFase 1
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 jun 2026 · NCT07422675Use of CereGate Therapy for Freezing of Gait in PD
- University of Miami, Miami
Reclutando
Edades de 21 a 80 · Todos los sexos · Actualizado el 28 may 2026 · NCT05292794A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Aqualane Clinical Research, Naples
- Charter Research, Orlando
- Progressive Medical Research, Port Orange
- y 2 más
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 30 a 85 · Todos los sexos · Actualizado el 20 abr 2026 · NCT06809400Electrophysiology-based DBS Programming for PD
- Norman Fixel Institute for Neurological Diseases, Gainesville
Reclutando
Edades de 21 a 89 · Todos los sexos · Actualizado el 30 mar 2026 · NCT07348705Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners
- Raw Kickboxing and Fitness, Coral Springs
- David Posnack Jewish Community Center, Davie
- Nova Southeastern University, Fort Lauderdale
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 feb 2026 · NCT06581523Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
- University of Florida, Gainesville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT06719583Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- University of South Florida - Department of Neurology, Tampa
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 8 ene 2026 · NCT04071847Globus Pallidus Stimulation to Treat Insomnia
- Mayo Clinic in Florida, Jacksonville
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 1 dic 2025 · NCT04116996Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- Parkinson's Disease & Movement Disorders Center of Boca Raton, Boca Raton
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2025 · NCT07219927A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Visionary Investigators Network, Aventura
- Parkinsons Disease and Movement Disorders Center of Boca Raton, Boca Raton
- Univesity of Miami - Miller School of Medicine, Boca Raton
- y 3 más
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2025 · NCT06765668Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Mayo Clinic Jacksonville, Jacksonville
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 18 a 80 · Todos los sexos · Actualizado el 2 may 2025 · NCT05395624Longitudinal Cognitive Assessment by BoCA
- Andrey Vyshedskiy, Miami
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 50 en adelante · Todos los sexos · Actualizado el 1 ago 2024 · NCT04114994Parkinson's Foundation Surveys
- Parkinson's Foundation, Miami
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 oct 2021 · NCT05066763De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.